The hypothesis of this work is that the extracellular matrix of bone both facilitates mineral nucleation and serves as the suprastructure for mineral deposition. The identification of bone specific matrix components, determination of their quantitative expression, the temporal regulation of their expression, and their assembly will provide a crucial understanding of the mechanisms of mineralization. Phosphoproteins have been identified as a possible matrix component that facilitates and controls mineralization in bone. IN order to further examine phosphoproteins' role in mineralization two specific phosphoproteins will be characterized at the protein level and subsequently cDNAs and genomic clones will be identified and analyzed. Their expression, levels of regulation and mechanisms of regulation will be analyzed during both in vivo bone development and in vitro development in a mineralizing osteoblast culture system. Two other genes associated with bone development (alkaline phosphatase and osteocalcin) and the general group of bone specific cDNAs, identified by subtractive hybridization screening, will be isolated. These genes will be similarly analyzed as the phosphoproteins. Their expression will also be examined during both in vitro and in vivo development and mineralization. These experiments will provide information on the role of phosphoproteins during bone development and mineralization. The comparative analysis of several different bone specific genes will provide a more complete view of the processes of cellular differentiation, and help identify the interaction of several bone specific proteins and the crucial molecular events of their quantitative and temporal expression during bone development and mineralization.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD022400-05
Application #
3321908
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Project Start
1987-01-01
Project End
1994-12-31
Budget Start
1991-01-01
Budget End
1991-12-31
Support Year
5
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Barnes, George L; Javed, Amjad; Waller, Sylvan M et al. (2003) Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res 63:2631-7
Barnes, George L; Della Torre, Thomas; Sommer, Beatrice et al. (2002) Transcriptional regulation restricting bone sialoprotein gene expression to both hypertrophic chondrocytes and osteoblasts. J Cell Biochem 87:458-69
Cullinane, Dennis M; Fredrick, Amy; Eisenberg, Solomon R et al. (2002) Induction of a neoarthrosis by precisely controlled motion in an experimental mid-femoral defect. J Orthop Res 20:579-86
Cho, Tae-Joon; Gerstenfeld, Louis C; Einhorn, Thomas A (2002) Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 17:513-20
Gerstenfeld, Louis C; Cruceta, Johanna; Shea, Colleen M et al. (2002) Chondrocytes provide morphogenic signals that selectively induce osteogenic differentiation of mesenchymal stem cells. J Bone Miner Res 17:221-30
Kon, T; Cho, T J; Aizawa, T et al. (2001) Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16:1004-14
Aizawa, T; Kon, T; Einhorn, T A et al. (2001) Induction of apoptosis in chondrocytes by tumor necrosis factor-alpha. J Orthop Res 19:785-96
Javed, A; Barnes, G L; Jasanya, B O et al. (2001) runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins. Mol Cell Biol 21:2891-905
Ranger, A M; Gerstenfeld, L C; Wang, J et al. (2000) The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis. J Exp Med 191:22-Sep
Gerstenfeld, L C; Toma, C D; Schaffer, J L et al. (1998) Chondrogenic potential of skeletal cell populations: selective growth of chondrocytes and their morphogenesis and development in vitro. Microsc Res Tech 43:156-73

Showing the most recent 10 out of 34 publications